Stay updated on Linvoseltamab Combo Therapy in Resistant Myeloma Clinical Trial
Sign up to get notified when there's something new on the Linvoseltamab Combo Therapy in Resistant Myeloma Clinical Trial page.

Latest updates to the Linvoseltamab Combo Therapy in Resistant Myeloma Clinical Trial page
- CheckyesterdayChange DetectedThe page now explicitly mentions Multiple myeloma and adds a related topics section with a MedlinePlus Genetics link; the site revision tag updates from v3.6.3 to v3.6.4.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedAdds the study title, EU CTIS number, and new dates for primary completion (2028-03-25) and study completion (2032-03-24). Also clarifies the cohort-based design, updated eligibility criteria, and drug administration details for the linvoseltamab-based regimens.SummaryDifference2%

- Check22 days agoChange DetectedThe page now shows an updated revision tag (Revision: v3.6.3), indicating a metadata update. Several topic keywords (e.g., Multiple myeloma, related topics, MedlinePlus Genetics) were removed from the page’s related-tag content.SummaryDifference0.1%

- Check36 days agoChange DetectedThe page now includes the disease term 'Multiple myeloma' and a 'related topics' section featuring 'MedlinePlus Genetics', enriching the study’s context and linking to genetics resources. This supports easier navigation and topic discovery for users interested in the condition and its genetic information.SummaryDifference0.1%

- Check43 days agoChange DetectedNew help/navigation links were added to improve user access (Check who can join, Find Contact Information, How to Read a Study Record, Common Questions, How to Join a Study). The Intervention/Treatment header was updated from 'Intervention / Treatment' to 'Intervention/Treatment' and the revision tag changed from v3.5.5 to v3.6.0.SummaryDifference0.3%

- Check50 days agoChange DetectedPage revision updated from v3.5.4 to v3.5.5, signaling a new build/version of the page. The change does not appear to modify study details or content visible to users.SummaryDifference0.0%

Stay in the know with updates to Linvoseltamab Combo Therapy in Resistant Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Linvoseltamab Combo Therapy in Resistant Myeloma Clinical Trial page.